DIN 02514931 — EVRYSDI 0.75 MG
EVRYSDI is a powder for solution of Risdiplam marketed by HOFFMANN-LA ROCHE LIMITED. The full Risdiplam monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02514931
- Brand name
- EVRYSDI
- Active ingredient
- Risdiplam
- Strength
- 0.75 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- ORAL
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- Survival motor neuron 2 (SMN2) pre-mRNA splicing modifier
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Risdiplam products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02560747 | EVRYSDI | 5 MG | TABLET | HOFFMANN-LA ROCHE LIMITED | MARKETED |